Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with age between 30-70 years with abnormal uterine bleeding. 2. Both parous and nulliparous women. 3. Patients not requiring emergency management. 4. Premenopausal with previously diagnosed leiomyoma and adenomyosis, polyp with ET > 12 mm. 5. Postmenopausal with previously diagnosed leiomyoma and adenomyosis with ET > 5 mm.
Exclusion criteria
Exclusion criteria: 1. Women with pregnancy related complications like threatened/incomplete/missed miscarriage and ectopic pregnancy, gestational trophoblastic diseases and haemostatic disorders were excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To study the histopathological pattern of endometrium in abnormal uterine bleeding(AUB) 2.To correlate the histopathological findings with demographic profile of the patient 3.To understand the relevance of endometrial samplings in the management of AUB.Timepoint: 1 & a half years | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To study the histopathological pattern of endometrium in abnormal uterine bleeding(AUB) 2.To correlate the histopathological findings with demographic profile of the patient 3.To understand the relevance of endometrial samplings in the management of AUB.Timepoint: 1 & a half years | — |
Countries
India
Contacts
KMC, Manipal